中国药物警戒 ›› 2011, Vol. 8 ›› Issue (7): 419-421.

• 管理及工作研究 • 上一篇    下一篇

我国药品上市后安全性监测现状的文献研究

宁艳阳1, 杨悦1, *, 魏晶2   

  1. 1.沈阳药科大学工商管理学院,辽宁 沈阳110016;
    2.辽宁省药品不良反应监测中心,辽宁 沈阳 110003
  • 收稿日期:2010-08-17 出版日期:2011-07-10 发布日期:2015-07-13
  • 通讯作者: *通讯作者：杨悦,女,博士,副教授,药事管理。E-mail: yyue315@126.com
  • 作者简介:宁艳阳,女,在读硕士研究生,药事管理。

Literature Review of Post-marketing Drug Safety Monitoring in China

NING Yan-yang1, YANG Yue1, *, WEI Jing2   

  1. 1.School of Business Administration, Shenyang Pharmaceutical University, Liaoning Shenyang 110016, China;
    2.Liaoning Adverse Drug Reaction Monitoring center, Liaoning Shenyang 110003, China
  • Received:2010-08-17 Online:2011-07-10 Published:2015-07-13

PDF (PC)

229

摘要： 目的 评价我国药品上市后安全性监测相关文献的研究现状。方法 对2000年至2010年4月CNKI发表的有关我国药品上市后安全性监测的文献进行检索、筛选,最终纳入对实际指导有重大意义的文献28篇,对纳入文献的基本情况以及我国药品上市后安全性监测的研究现状进行描述。结果 与结论 我国药品上市后安全性监测研究主要集中在药品不良反应监测、药物警戒、国外药品上市后安全性监测三个方面,研究数量呈总体上升趋势,且研究越来越受到关注。

关键词: 文献研究, 药品上市后安全性监测, 药品不良反应监测, 药物警戒

Abstract: Objective To master the research progress in the field of post-marketing drug safety monitoring in China.Methods This aticle searched and screened documents about post-marketing drug safety monitoring in CNKI from 2000 to 2010 April, included 28 instructive literatures. The article described the basic information of 28 literatures, and research status of post-marketing drug safety monitoring in China. The research of post-marketing drug safety monitoring in China was concentrated in ADR monitoring, pharmacovigilance and foreign information.Results＆Conclusion Number of literatures showed an overall upward trend. Study of post-marketing drug safety monitoring would get more and more attention.

Key words: literature review, post-marketing drug safety monitoring, adverse drug reaction(ADR) monitoring, pharmacovigilance

中图分类号: